The same author analyzed 1171 unmatched ovarian cancer cases and investigated the presence of selected BRCA1 and BRCA2 mutations and, on the basis of his data, showed that the relative risk of developing stomach cancer in BRCA1 mutation carriers was 4.8 (95 % CI 1.5–15) [27]. This evidence concerns the gene BRCA1 and gastric neoplasm.